Exhaled carbon monoxide levels in children with sickle cell disease
- PMID: 15599764
- DOI: 10.1007/s00431-004-1605-8
Exhaled carbon monoxide levels in children with sickle cell disease
Abstract
It is important to measure the rate of haemolysis in patients with sickle cell disease (SCD) to identify aplastic crises and indirectly assess the rate of vaso-occlusion and sequestration. The aim of this study was to assess whether end-tidal carbon monoxide (ETCOc) levels in children with sickle cell disease (SCD) could be measured reproducibly, reflected haemolysis and whether they were elevated compared to those of similarly aged, ethnic matched children without SCD (controls). ETCOc levels were measured non-invasively in 87 SCD children (age range 2.3-17.6 years) and 26 age and ethnic origin matched healthy controls using an electro-chemical sensor. The within- and between- occasion reproducibilities were assessed in ten and 15 SCD children respectively. ETCOc levels of 15 SCD children undergoing regular transfusions were related to carboxyhaemoglobin, haemoglobin and bilirubin levels. The within and between occasions' mean intrasubject coefficients of reproducibility were 5% and 18% respectively. Positive correlations were found between the ETCOc and carboxyhaemoglobin ( P =0.007) and bilirubin ( P =0.02) levels, and a significant negative correlation between the ETCOc and haemoglobin ( P =0.0002) levels. The mean and SD ETCOc levels of the SCD children (4.9 ppm; SD 1.7 ppm) were significantly higher than that of the controls (mean 1.3 ppm; SD 0.4 ppm) (difference between means 3.60; 95% C.I. 2.93-4.28; P <0.0001).
Conclusion: These results suggest that measurement of end-tidal carbon monoxide levels is a reliable and useful method to monitor haemolysis in children with sickle cell disease.
Similar articles
-
End-tidal carbon monoxide and hemolysis.J Perinatol. 2014 Aug;34(8):577-81. doi: 10.1038/jp.2014.66. Epub 2014 Apr 17. J Perinatol. 2014. PMID: 24743136 Review.
-
Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.Pediatr Blood Cancer. 2015 May;62(5):912-4. doi: 10.1002/pbc.25447. Epub 2015 Feb 14. Pediatr Blood Cancer. 2015. PMID: 25683629 Free PMC article.
-
Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy.Pediatr Hematol Oncol. 2010 Mar;27(2):112-21. doi: 10.3109/08880010903536227. Pediatr Hematol Oncol. 2010. PMID: 20201692
-
Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis.Neonatology. 2016;109(1):1-5. doi: 10.1159/000438482. Epub 2015 Sep 23. Neonatology. 2016. PMID: 26394287
-
Neonatal/perinatal diagnosis of hemolysis using ETCOc.Semin Fetal Neonatal Med. 2025 Mar;30(1):101547. doi: 10.1016/j.siny.2024.101547. Epub 2024 Oct 22. Semin Fetal Neonatal Med. 2025. PMID: 39455373 Review.
Cited by
-
Anesthesia-Related Carbon Monoxide Exposure: Toxicity and Potential Therapy.Anesth Analg. 2016 Sep;123(3):670-81. doi: 10.1213/ANE.0000000000001461. Anesth Analg. 2016. PMID: 27537758 Free PMC article. Review.
-
End-tidal carbon monoxide and hemolysis.J Perinatol. 2014 Aug;34(8):577-81. doi: 10.1038/jp.2014.66. Epub 2014 Apr 17. J Perinatol. 2014. PMID: 24743136 Review.
-
Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.Pediatr Blood Cancer. 2015 May;62(5):912-4. doi: 10.1002/pbc.25447. Epub 2015 Feb 14. Pediatr Blood Cancer. 2015. PMID: 25683629 Free PMC article.
-
Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability.Dev Sci. 2006 Jul;9(4):411-27. doi: 10.1111/j.1467-7687.2006.00507.x. Dev Sci. 2006. PMID: 16764614 Free PMC article. Review.
-
Cardiovascular biomarkers in exhaled breath.Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):34-43. doi: 10.1016/j.pcad.2012.05.005. Prog Cardiovasc Dis. 2012. PMID: 22824108 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical